This proposal requests continued support for the Medical Scientist Training Program (MSTP) at Vanderbilt University. The Vanderbilt MSTP provides students a strong medical education and rigorous in depth training in the scientific method. Our 51 students come from 44 colleges representing all regions of the U.S. Our applicant pool is large and growing: 277 students applied for admission into the MSTP for the 1998 class, from among whom 10 will enter the Program. The institution has made a financial commitment to support growth of the Program to a steady state of 70-75 students over the next five years. Programmatic identify is provided by weekly MSTP Conjoint Seminars, the Summer Retreat, monthly """"""""Fireside Chats"""""""" with scientific leaders, and an annual MSTP Picnic. Students participate in discussions, not only of science but also responsible scientific conduct, and also business and entrepreneurial skill. Seventy percent of our graduates hold academic positions at the Assistant Professor level or higher. Our graduates who are out in their careers are PI's on 24 NIH extramural grants including 4 program project grants. The 34% of graduates still in-training are in excellent residencies and fellowships. Vanderbilt University has an outstanding faculty of 1,021 of whom 293 are basic scientists. Our Pharmacology Department ranks first nationally in NIH funding, and our Biochemistry and our Physiology Departments each rang second. our faculty attract $87.3 million in federally sponsored research and $44.3 in non-federal support. We request a growth in support from 17 to 25 during the five year project period, with the planned growth of the Vanderbilt MSTP to 70-75 students. This increase in requested growth would provide 27.3% of total program cost in 2003; the grant currently supports 28.4% of program cost.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007347-23
Application #
6350959
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Shapiro, Bert I
Project Start
1977-07-01
Project End
2004-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
23
Fiscal Year
2001
Total Cost
$834,900
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Miscellaneous
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
McKenna, Matthew T; Weis, Jared A; Quaranta, Vito et al. (2018) Variable Cell Line Pharmacokinetics Contribute to Non-Linear Treatment Response in Heterogeneous Cell Populations. Ann Biomed Eng 46:899-911
Kozek, Krystian A; Du, Yu; Sharma, Swagat et al. (2018) Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels. ACS Chem Neurosci :
Sundermann, Alexandra C; Saum, Keith; Conrad, Kelsey A et al. (2018) Prognostic value of D-dimer and markers of coagulation for stratification of abdominal aortic aneurysm growth. Blood Adv 2:3088-3096
Athmer, Jeremiah; Fehr, Anthony R; Grunewald, Matthew E et al. (2018) Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon Responses. MBio 9:
Feng, QiPing; Wei, Wei-Qi; Chung, Cecilia P et al. (2018) Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records. PLoS Med 15:e1002642
Burns, Michael C; Howes, Jennifer E; Sun, Qi et al. (2018) High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling. Anal Biochem 548:44-52
Zamora, Paula F; Hu, Liya; Knowlton, Jonathan J et al. (2018) Reovirus Nonstructural Protein ?NS Acts as an RNA Stability Factor Promoting Viral Genome Replication. J Virol 92:
Earl, David C; Ferrell Jr, P Brent; Leelatian, Nalin et al. (2018) Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomics. Nat Commun 9:39
Hartmann, Katherine E; Velez Edwards, Digna R; Savitz, David A et al. (2018) THE AUTHORS REPLY. Am J Epidemiol 187:1133-1134
Trubiano, Jason A; Strautins, Kaija; Redwood, Alec J et al. (2018) The Combined Utility of Ex Vivo IFN-? Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions. J Allergy Clin Immunol Pract 6:1287-1296.e1

Showing the most recent 10 out of 536 publications